The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders
Nutrients · 20.07.2025 · 17 (14) · 2374
DOI: 10.3390/nu17142374 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 20.07.2025. Verfasst von Grzegorz K Jakubiak und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Zabrze, Poland. Hauptthemen laut MEDLINE: Intra-Abdominal Fat, Metabolic Syndrome, Cardiovascular Diseases, Adiposity. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Obesity is currently one of the most critical public health problems. Although there is no doubt that obesity is a significant risk factor for developing metabolic disorders, this relationship is not completely straightforward. On the one hand, some patients affected by obesity are metabolically unhealthy, while others are metabolically healthy; on the other hand, metabolic syndrome (MetS) can also occur in people with a normal body weight. A commonly used tool for diagnosing obesity is the body mass index (BMI), but the search for better anthropometric measures is ongoing due to the significant limitations of this measure. Obesity can lead to MetS and cardiovascular diseases (CVDs). Adipose tissue dysfunction is the fundamental mechanism linking obesity and cardiometabolic diseases, which is rooted in the disturbed secretion of adipokines. The visceral adiposity index (VAI) is calculated based on the BMI, waist circumference (WC), blood triglycerides (TG), and high-density lipoprotein cholesterol (HDL-C) concentrations. It was proposed in 2010 by Amato et al. as a parameter indicating adipose tissue dysfunction and cardiometabolic risk. According to the research conducted so far, some data confirm a relationship between the VAI value and the risk of developing prediabetes, diabetes, insulin resistance, fatty liver disease, MetS, CVD, and chronic kidney disease. Further research is needed to support the implementation of VAI assessment in routine clinical practice. The purpose of this paper is to present the results of a narrative literature review summarizing current knowledge regarding the VAI and its usefulness in clinical practice for assessing cardiometabolic risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Zabrze, Poland.
- Department of Physical Education and Special Motricity, Transilvania University of Brasov, 500068 Brașov, Romania.
- Department of Internal Medicine and Clinical Pharmacology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
ORCID-Profile: Grzegorz K Jakubiak, Georgian Badicu, Ewa Waluga-Kozłowska, Natalia Pawlas
Zitieren
APA
Jakubiak, G. K., Badicu, G., Surma, S., Waluga-Kozłowska, E., Chwalba, A., & Pawlas, N. (2025). The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders. Nutrients, 17(14), 2374. https://doi.org/10.3390/nu17142374
Vancouver
Jakubiak GK, Badicu G, Surma S, Waluga-Kozłowska E, Chwalba A, Pawlas N. The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders. Nutrients. 2025;17(14):2374. doi:10.3390/nu17142374
BibTeX
@article{Jakubiak2025,
author = {Jakubiak, Grzegorz K and Badicu, Georgian and Surma, Stanisław and Waluga-Kozłowska, Ewa and Chwalba, Artur and Pawlas, Natalia},
title = {The Visceral Adiposity Index and Its Usefulness in the Prediction of Cardiometabolic Disorders},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {14},
pages = {2374},
doi = {10.3390/nu17142374}
}
EUVIMED